The pharmaceutical industry's next billion-dollar blockbuster won't come from a lab alone—it will come from listening to ...

Researchers have added to fears around the drug, however, after calling for ‘urgent attention’ following a discovery that ...

The National Institutes of Health (NIH) in the USA is currently building a national autism registry that will be populated ...

Short Summary The EU, UK, and USA each have distinct and evolving regulatory systems for medicines and medical devices, involving strict approval, surveillance, and market access requirements managed ...

Patients are losing out on life-changing drugs for cancer and rare diseases because of Brexit, experts have warned. Treatments could be made available in the EU and US before the UK because of cost ...

Shares of Ascendis Pharma (ASND) are down $5.82, or 4%, to $155.33 in morning trading in New York. The move lower began near the open and may ...

The European Commission said Wednesday that it had given formal approval for Leqembi, a long-awaited new treatment for ...

A group of expert neurologists have expressed concerns at the European Commission’s (EC) decision to formally approve the Alzheimer’s drug lecanemab (Leqembi) despite uncertain benefits. Lecanemab, ...

Organoids and synthetic embryos mark a pivotal shift in biomedical research, highlighting the need for ethical oversight amid ...

Pfizer has been paying dividends for 35 years and raising them for 14 years. Read more to see whether PFE stock is a buy.

The FDA did not agree with a supplemental Biologics License Application for the addition of extended dosing intervals of up ...

The pharmaceutical industry faces environmental challenges. Green chemistry offers sustainable solutions to reduce waste and ...